In this section you will be able to access our latest financial reports and presentations, keep up to date with share price trends, and shareholder updates.

Share information

Share chart


  • Company Overview

    Purpose built for a new era of media and a new generation of consumers who behave drastically different to previous generations. Our brands and team sit in the intersection between culture, tech and community, well positioned to adapt, advise and capitalise on emerging trends. Our unique position combined with our team of inhouse specialists both, allow us to build our own brands and also help other brands solve business problems, and get fit for the digital age.

  • Company Strategy

    Iconic Labs is a multi-divisional new media and technology business positioned to deliver best-in-class consultancy, products, marketing and distribution. It is a consumer-first business that utilises data & insights to exploit new trends and develop disruptive technologies with a focus on future generations.

    Our current focus is to expand our content platform, suite of digital brands, and technology products both organically and through acquisitions.

  • Corporate Governance

    As a company with a Standard Listing, the Company is not required to comply with the provisions of the Corporate Governance Code. However, in the interests of observing best practice on corporate governance, the Company intends to comply with the provisions of the Corporate Governance Code insofar as is appropriate having regard to the size and nature of the Company and the size and composition of the Board.

    Audit Committee

    The Audit Committee comprises David Sefton and John Quinlan. The Board is satisfied that at least one member of the committee has recent, relevant, financial experience. The main roles and responsibilities include:

    • to monitor in discussion with the auditors the integrity of the financial statements of the Company, and any formal announcements relating to the Company’s financial performance, reviewing significant financial reporting judgments contained in them;

    • to review the Company’s internal financial controls and, unless expressly addressed by a separate board risk committee composed of independent directors, or by the board itself, to review the Company’s internal control and risk management systems;

    • to monitor and review the effectiveness of the Company’s internal audit functions and, where there is no internal audit function, consider annually whether there is a need for an internal audit function and make a recommendation to the board;

    • to make recommendations to the board, for it to put to the shareholders for their approval in the general meeting, in relation to the appointment, reappointment and removal of the external auditor and to approve the remuneration and terms of engagement of the external auditor;

    • to review and monitor the external auditor’s independence and objectivity and the effectiveness of the audit process, taking into consideration relevant UK professional and regulatory requirements;

    • to develop and implement policy on the engagement of the external auditor to supply non-audit services, taking into account relevant external guidance regarding the provision of non-audit services by the external audit firm; and to report to the board, identifying any matters in respect of which it considers that action or improvement is needed and making recommendations as to the steps to be taken;

    • to review arrangements by which staff of the Company may, in confidence raise concerns about possible improprieties in matters of financial reporting or other matters and ensure that arrangements are in place for the proportionate and independent investigation of such matters with appropriate follow-up action

    Remuneration Committee

    The Remuneration Committee will comprise David Sefton and Liam Harrington. The Committee’s responsibilities will include:

    • to determine and agree with the board the framework or broad policy for the remuneration of the chief executive, the chairman of the Company (where executive) and such other members of the executive management as it is designated to consider;

    • to make recommendations and monitor the level and structure of remuneration for senior management;

    • to set the remuneration of non-executive directors (including the chairman if non-executive);

    • to determine and approve targets for any performance-related pay schemes operated by the Company;

    • to ensure that contractual terms on termination, and any payments made, are fair to the individual and the Company;

    • within the terms of the agreed policy, to determine the total individual remuneration package of each executive director including, where appropriate, bonuses, incentive payments and share options;

    • to co-ordinate closely with the Nomination Committee in relation to the remuneration to be offered to any new executive director;

    • to be aware of and advise on any major changes in employees benefit structures throughout the Company or group;

    • to agree the policy for authorising claims for expenses from the chief executive and chairman.

    Nomination Committee

    As the size and operations of Iconic Labs plc change, the Company will need to consider whether the skills and characteristics of its Board are appropriate. The Nomination Committee will comprise John Quinlan, Will Muirhead and David Sefton and their responsibilities will include:

    • to interview and consider potential appointments and reappointments to the Board of the Company;

    • to assess the skills and experience of the Board to ensure any deficiencies are addressed with new appointments;

    • to ensure that Directors are placed up for renewal and/or re-election as required under the Company’s constitution.

    Share Dealing Policy

    The Board has implemented high level internal controls to ensure compliance with the Market Abuse Regulations as it applies to employees dealing in shares of the Company. This document will be reviewed regularly at Board meetings.

    Bribery and Corruption Policy

    The Board will adopt a Bribery and Corruption Policy consistent with the requirements of the UK Bribery Act 2010.  Compliance with the policy will be regularly reviewed at Board meetings.

  • Advisors


    Shard Capital Partners LLP
    23rd Floor, 20 Fenchurch St,
    London, EC3M 3BY


    DLA Piper UK LLP
    3 Noble Street
    London, EC2V 7EE


    Crowe U.K. LLP
    55 Ludgate Hill,
    London, EC4M 7JW


    Gladstone House
    77-79 High Street,
    TW20 9HY


    MSP Corporate Services
    27/28 Eastcastle Street
    London, W1W 8DH


    SLC Registrars Limited
    Elder House
    St Georges Business Park
    Brooklands Road
    Surrey, KT12 0TS

  • IR Contacts

    Contact Details

    For any queries that have not been answered in the Q&A documents please get in touch vie email or call our investor relations department, and the company will endeavour to answer your query in the next Q&A document.


    [email protected]


    +44 (0)333 555 2508

    +44 (0)844 487 4939